On August 1, a scheduled meeting of the Board of Directors of JSC “National Holding QazBioPharm” was held under the chairmanship of Darkhan Mynbay. During the meeting, key issues regarding the Holding’s activities for the first half of 2025 were discussed.

The agenda included reports on the implementation of the Development Plan, financial performance, as well as results of the work of divisions accountable to the Board of Directors. Particular attention was paid to a presentation on the current corporate structure of the Holding and the operations of its subsidiaries.

Following the meeting, relevant recommendations were provided, and a number of decisions were made aimed at enhancing the scientific and production potential of the Holding.

The meeting also marked the renewal of the Board of Directors’ composition. New members were approved in accordance with the established procedure, taking into account their professional experience and the competencies required to fulfill the strategic objectives of the Holding.

JSC “National Holding QazBioPharm” continues to pursue sustainable development, implement cutting-edge scientific solutions, and strengthen Kazakhstan’s position in the field of biopharmaceuticals and biological safety.